XM does not provide services to residents of the United States of America.
J
J

JohnsonMatthey

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Hybrid cars throw lifeline to platinum metals

ANALYSIS-Hybrid cars throw lifeline to platinum metals Demand for plug-in hybrids surges as EV take-up slows Some plug-in hybrids require more PGMs than petrol cars PGM market volatility could pick up if supply curtailed By Eric Onstad and Polina Devitt LONDON, Sept 9 (Reuters) - A surge in sales of hybrid cars as electric vehicle take-up slows is set to provide an unexpected boost to demand for platinum group metals (PGMs) in the coming years, similar to the extended lifespan now predicted for
G
A
J

Johnson Matthey Appoints Sinead Lynch As Non-Executive Director

BRIEF-Johnson Matthey Appoints Sinead Lynch As Non-Executive Director Sept 9 (Reuters) - Johnson Matthey PLC JMAT.L : JOHNSON MATTHEY PLC - DIRECTORATE CHANGE JOHNSON MATTHEY PLC - SINEAD LYNCH TO JOIN JOHNSON MATTHEY AS NON-EXECUTIVE DIRECTOR Source text for Eikon: ID:nRSI3088Da Further company coverage: JMAT.L
J

Carnival, Kingfisher, Unite Group

EUROPE RESEARCH ROUNDUP-Carnival, Kingfisher, Unite Group Sept 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Carnival, Kingfisher and Unite Group on Monday. HIGHLIGHTS * Believe SA BLV.PA : Citigroup resumes coverage with neutral rating; PT EUR 15 * Carnival CCL.L : HSBC raises target price to 960p from 895p * Derwent London DLN.L : Morgan Stanley raises target price to 3000p from 2750p * Kingfisher Plc KGF.L : Barclays cuts to
B
B
B
C
C
C
D
D
E
F
G
H
I
I
K
K
L
N
S
S
V
P
B
J
M
P
S

Johnson Matthey Completion Of Medical Device Components Sale

BRIEF-Johnson Matthey Completion Of Medical Device Components Sale July 1 (Reuters) - Johnson Matthey PLC JMAT.L : JOHNSON MATTHEY PLC - COMPLETION OF MEDICAL DEVICE COMPONENTS SALE JOHNSON MATTHEY PLC - TO RETURN £250 MILLION VIA SHARE BUYBACK PROGRAMME Source text for Eikon: ID:nRSA5829Ua Further company coverage: JMAT.L
J

Bechtle AG, Centrica, Clariant AG

EUROPE RESEARCH ROUNDUP-Bechtle AG, Centrica, Clariant AG July 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bechtle AG, Centrica and Clariant AG, on Monday. HIGHLIGHTS * Akzo Nobel NV AKZO.AS : Goldman Sachs cuts to sell from neutral * Bechtle AG BC8G.DE : Exane BNP Paribas cuts to underperform from neutral * Centrica CNA.L : Berenberg raises to buy from hold * Clariant AG CLN.S : Goldman Sachs raises to buy from neutral * Fin
A
A
A
A
B
B
B
C
C
C
D
D
H
H
P
S
S
A
A
F
J

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.